Hiv Prevention
-
{
- All
- News
-
New HIV Pill Delivers Breakthrough Results In First Human Trial
Researchers say the treatment appears safe and effective so far, although larger Phase 3 trials will be needed before it can be approved for widespread use.
-
Nepal Aid Workers Turn To Sex Work After Donald Trump's USAID Cuts
Of the more than 281,000 jobs lost due to Trump's dismantling of USAID, just 23,000 were American, says Sadie Healy, who runs a global health consulting firm and has been tracking the job losses worldwide.
-
New HIV Vaccine Offers Strong Protection Against The Virus: What The Study Found
Instead of targeting HIV directly, the new vaccine focuses on training the immune system to produce powerful antibodies capable of recognising many different HIV strains.
-
Highly Effective Prevention Drug Arrives In South Africa, Which Has World's Highest HIV Burden
South Africa launches lenacapavir, a twice-yearly injectable HIV prevention drug, aiming to reduce new infections in the country with the highest HIV burden globally.
-
Cambodia Hits 95-95-95 HIV Targets, On Track To End AIDS By 2030: Health Minister
Phnom Penh, May 30 (IANS) Cambodia achieved its 95-95-95 HIV treatment targets last year, and is on track to eliminate AIDS as a public health threat by 2030, the country's Minister of Health Chheang Ra has said.
-
"Fresh Hope": Groundbreaking HIV Prevention Shots Begin In Africa
South Africa, Eswatini and Zambia on Monday began administering a groundbreaking new HIV-prevention injection in the drug's first public rollouts in Africa, which has the world's highest HIV burden.
-
Global HIV Response Facing Worst Setback In Decades Amid 2025 Funding Cuts: New Report
A new report released by the Joint United Nations Programme on HIV/AIDS (UNAIDS) warns that the global HIV response has suffered its most significant setback in decades, urging reliance on solidarity, resilience, investment and
-
Global HIV Response Facing Worst Setback In Decades Amid 2025 Funding Cuts: New Report
A new report released by the Joint United Nations Programme on HIV/AIDS (UNAIDS) warns that the global HIV response has suffered its most significant setback in decades, urging reliance on solidarity, resilience, investment and
-
Every-2-Month HIV Prevention Breakthrough Shot Approved By UK: Will India Follow?
The UK has approved a long-acting injection for HIV prevention, administered every two months. Experts say it marks a major step in public-health tools, but complex issues of access and cost raise questions for India.
-
Every-2-Month HIV Prevention Breakthrough Shot Approved By UK: Will India Follow?
The UK has approved a long-acting injection for HIV prevention, administered every two months. Experts say it marks a major step in public-health tools, but complex issues of access and cost raise questions for India.
-
EU Regulator Approves Twice-Yearly Injectable Drug For HIV Prevention
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
Long-Term HIV Preventative Treatment To Be Accessible In Low-Income Nations
A deal has been reached to allow for distribution of a low-cost generic version of a long-term preventative treatment against HIV in low-income countries where most of the world's infections occur.
-
Bill Gates Invests $140 Million In Groundbreaking New Technology For HIV Cure
Microsoft founder Bill Gates' charity foundation has invested USD 140 million in the development of HIV-preventing drug implants that could revolutionise the treatment of the life-threatening infection.
-
Bill Gates Invests $140 Million In Groundbreaking New Technology For HIV Cure
Microsoft founder Bill Gates' charity foundation has invested USD 140 million in the development of HIV-preventing drug implants that could revolutionise the treatment of the life-threatening infection.
-
New HIV Pill Delivers Breakthrough Results In First Human Trial
Researchers say the treatment appears safe and effective so far, although larger Phase 3 trials will be needed before it can be approved for widespread use.
-
Nepal Aid Workers Turn To Sex Work After Donald Trump's USAID Cuts
Of the more than 281,000 jobs lost due to Trump's dismantling of USAID, just 23,000 were American, says Sadie Healy, who runs a global health consulting firm and has been tracking the job losses worldwide.
-
New HIV Vaccine Offers Strong Protection Against The Virus: What The Study Found
Instead of targeting HIV directly, the new vaccine focuses on training the immune system to produce powerful antibodies capable of recognising many different HIV strains.
-
Highly Effective Prevention Drug Arrives In South Africa, Which Has World's Highest HIV Burden
South Africa launches lenacapavir, a twice-yearly injectable HIV prevention drug, aiming to reduce new infections in the country with the highest HIV burden globally.
-
Cambodia Hits 95-95-95 HIV Targets, On Track To End AIDS By 2030: Health Minister
Phnom Penh, May 30 (IANS) Cambodia achieved its 95-95-95 HIV treatment targets last year, and is on track to eliminate AIDS as a public health threat by 2030, the country's Minister of Health Chheang Ra has said.
-
"Fresh Hope": Groundbreaking HIV Prevention Shots Begin In Africa
South Africa, Eswatini and Zambia on Monday began administering a groundbreaking new HIV-prevention injection in the drug's first public rollouts in Africa, which has the world's highest HIV burden.
-
Global HIV Response Facing Worst Setback In Decades Amid 2025 Funding Cuts: New Report
A new report released by the Joint United Nations Programme on HIV/AIDS (UNAIDS) warns that the global HIV response has suffered its most significant setback in decades, urging reliance on solidarity, resilience, investment and
-
Global HIV Response Facing Worst Setback In Decades Amid 2025 Funding Cuts: New Report
A new report released by the Joint United Nations Programme on HIV/AIDS (UNAIDS) warns that the global HIV response has suffered its most significant setback in decades, urging reliance on solidarity, resilience, investment and
-
Every-2-Month HIV Prevention Breakthrough Shot Approved By UK: Will India Follow?
The UK has approved a long-acting injection for HIV prevention, administered every two months. Experts say it marks a major step in public-health tools, but complex issues of access and cost raise questions for India.
-
Every-2-Month HIV Prevention Breakthrough Shot Approved By UK: Will India Follow?
The UK has approved a long-acting injection for HIV prevention, administered every two months. Experts say it marks a major step in public-health tools, but complex issues of access and cost raise questions for India.
-
EU Regulator Approves Twice-Yearly Injectable Drug For HIV Prevention
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
Long-Term HIV Preventative Treatment To Be Accessible In Low-Income Nations
A deal has been reached to allow for distribution of a low-cost generic version of a long-term preventative treatment against HIV in low-income countries where most of the world's infections occur.
-
Bill Gates Invests $140 Million In Groundbreaking New Technology For HIV Cure
Microsoft founder Bill Gates' charity foundation has invested USD 140 million in the development of HIV-preventing drug implants that could revolutionise the treatment of the life-threatening infection.
-
Bill Gates Invests $140 Million In Groundbreaking New Technology For HIV Cure
Microsoft founder Bill Gates' charity foundation has invested USD 140 million in the development of HIV-preventing drug implants that could revolutionise the treatment of the life-threatening infection.
